| 摘要 |
The present invention relates to compounds of formula (I) wherein R1, R2, R3 , R4, R5 and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof, for use as therapeutically active substances. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB 1 receptors.
|
